Tramadol is a prescription painkiller used for moderate to severe pain relief. It works by binding to opioid receptors in the brain and spinal cord, reducing pain perception.

Biosion has received approval from the FDA for its investigational new drug application concerning BSI-082, an innovative monoclonal antibody targeting SIRPα.

Sertraline, a widely used SSRI drug for treating depression, anxiety, and OCD in adults and children, affects brain neurotransmitter interactions.

CDR-Life revealed the FDA's approval for clinical trial application for their drug, CDR404, aimed at addressing solid tumor conditions.

Doxycycline is a tetracyclin-like broad-spectrum antibiotic that stops bacteria from growing and replicating by inhibiting the synthesis of bacterial proteins.

Omeprazole, a common PPI, is used to treat gastrointestinal conditions like GERD, peptic ulcers, and Zollinger-Ellison syndrome.

Long-term results show Opdivo combined with Yervoy outlasts Sunitinib in survival outcomes for advanced or metastatic kidney cancer patients who haven't received prior treatment over an 8-year period.

Lisinopril is an ACE inhibitor often prescribed for hypertension, heart failure, and other heart conditions.

Vanda Pharmaceuticals Granted Green Light by FDA to Advance with Experimental Antisense Oligonucleotide Therapy, VCA-894A, for Managing Charcot-Marie-Tooth Disease, Subtype 2S.

Hydroxyzine is a first-generation antihistamine that is commonly used for the treatment of various allergic conditions such as hives and itching.

Fentanyl, a tiny molecule drug, is a COX-2 inhibitor that specifically targets the COX-2 enzyme causing inflammation and pain.

Opdivo® (nivolumab) and CABOMETYX® (cabozantinib) Show Long-Term Survival in 4-Year CheckMate-9ER Trial for 1st-Line Advanced RCC.